Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Markers of Bone Destruction and Oxidative Stress in Peri-implantitis

Official title: Evaluation of Bone Destruction and Oxidative Stress Markers in Saliva and Peri-implant Sulcus Fluid in Peri-implantitis

Run by Saglik Bilimleri Universitesi · NCT07397884 · Data updated 2026-11-12

This study tests whether saliva and peri-implant sulcular fluid reflect bone loss and inflammation in peri-implantitis, periodontitis, and healthy teeth to help with early detection.

More Periodontal Diseases trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment80 (estimated)
SponsorSaglik Bilimleri Universitesi
Academic / other
Locations1 site (Keçiören, Ankara)
StatusRecruiting
StartedFebruary 15, 2026
Main results expectedNovember 15, 2026
Study endsNovember 20, 2026
Registry record updatedSeptember 29, 2026
Trial IDNCT07397884 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Systemically healthy adults aged 18–65 with peri-implantitis, periodontitis, or healthy implants/teeth meeting the respective inclusion criteria.

Probably not a fit

Patients without peri-implantitis or periodontitis or those whose biomarkers do not correlate with disease status may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will compare biomarkers of bone resorption (RANKL, OPG), oxidative stress (nitrotyrosine, NQO1), and a pro-inflammatory cytokine (IL-1β) in saliva and peri-implant sulcular fluid across four groups: peri-implantitis, periodontitis, and healthy peri-implant and periodontal sites. Participants will be 18–65 years old and categorized based on clinical and radiographic criteria. Samples will be collected under standardized conditions, with clinical parameters (PI, GI, BOP, PD, CAL) recorded at six sites per tooth or implant. Analyses will aim to determine the diagnostic value of these biomarkers for early detection and progression of peri-implant diseases.

Why it matters

Potential benefit: If successful, biomarkers could improve early detection and monitoring of peri-implant disease risk and progression.

How similar studies have gone: Previous research has shown associations between inflammatory and oxidative stress markers and periodontal diseases; this study adds peri-implant contexts and direct comparisons.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Systemically healthy volunteers aged 18-65. For Peri-implantitis group: Implants in function for ≥1 year, radiographic bone loss ≥ 2 mm, probing depth (PD) ≥ 5 mm, and presence of bleeding on probing (BOP) or suppuration.

For Periodontitis group: At least one tooth with PD ≥ 4 mm, presence of BOP, and radiographic bone loss.For Healthy groups: PD ≤ 3 mm, no clinical inflammation (BOP-), and no radiographic bone loss.

(According to the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases) -

Exclusion Criteria:Presence of systemic diseases (e.g., diabetes, rheumatoid arthritis, osteoporosis).

Use of antibiotics, anti-inflammatory, or immunosuppressive drugs within the last 3 months.

Pregnancy or breastfeeding.

Smoking (current smokers).

History of periodontal or peri-implant surgical treatment within the last 6 months.

Implant failure (mobility).

Signs of acute infection (fever, systemic symptoms).

\-

Where it's running

  • Gülhane Faculty of Dentistry, University of Health Sciences
    Keçiören, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Gülbahar Ustaoğlu, Professor — University of Health Sciences, Gulhane Faculty of Dentistry, Department of Periodontology
  • Study coordinator: Nurullah Yurdakul, Dr.
  • Email: nurullah.yurdakul@sbu.edu.tr
  • Phone: +905340757662

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.